These results, together with a earlier report displaying that a little-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 support the concept of targeting ACKR3 as a unique method to modulate the opioid process, which could open new therapeutic avenues for opioid-similar Diseases. Once in a while I receive https://charliek284arf9.eqnextwiki.com/user